One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: A randomized, placebo-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2007, Pages 665-672

  Van Zanten, S V ^a   Flook, N ^b   Talley, N J ^c,d,h   Vakil, N ^e   Lauritsen, K ^f   Bolling Sternevald, E ^g   Persson, T ^g   Bjorck E ^g   Svedberg, L E ^g  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Mayo Clinic   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g ASTRAZENECA R AND D   (Sweden)

^h MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PLACEBO;

ABDOMINAL DISTENTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DYSPEPSIA; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FEMALE; HELICOBACTER PYLORI; HUMAN; INHIBITION KINETICS; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID; STOMACH PH; TRANSITIONAL BLINDNESS; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; URTICARIA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPEPSIA; FEMALE; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PLACEBOS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34547852247     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03409.x     Document Type: Article

References (18)

1. Talley NJ, Stanghellini V, Heading R, Kock KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders: a working team report for the Rome II consensus on functional gastrointestinal disorders. Gut 1999 45 (Suppl. 2 II37 42.
2. Veldhuyzen van Zanten S, Flook N, Chiba N, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. CMAJ 2000 12 (Suppl. S3 23.
3. The British Society of Gastroenterology guidelines on dyspepsia. Available at: http://www.bsg.org.uk/pdf_word_docs/dyspepsia.doc, 2007.
4. Talley N, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005 129:1756 80.
5. Talley NJ, Vakil N. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005 100:2324 37.
6. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998 12:1055 65.
7. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003 1:CD001960.
8. Peura DA, Kovacs TOG, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double blind, randomized, placebo-controlled trials. Am J Med 2004 116:740 8.
9. Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group. Gastroenterology 1994 107:1305 11.
10. Altman DG, Bland JM. Diagnostic tests: 1. Sensitivity and specificity. Br Med J 1994 308:1552.
11. Rao G. Number needed to treat. J Fam Pract 2003 52:866.
12. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999 45 (Suppl. 2 II69 77.
13. Meineche-Schmidt V. Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12 month follow-up of health-care consumption. Am J Gastroenterol 2004 99:1050 8.
14. Veldhuyzen van Zanten S, Chiba N, Armstrong D, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol 2005 100:1477 88.
15. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996 91:660 73.
16. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006 130:1466 79.
17. Goves J, Oldring JK, Kerr D, et al. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther 1998 12:147 57.
18. Rabeneck L, Souchek J, Wristers K, et al. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia. Am J Gastroenterol 2002 97:3045 51.